Quick Takeaways
- AWM Investment Company, Inc. filed SCHEDULE 13G/A for Oncocyte Corp Common Stock (OCX).
- Disclosed ownership: 7.5%.
- Date of event: 31 Dec 2024.
AWM Investment Company, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for Oncocyte Corp Common Stock (OCX)
- Filing Manager
- AWM Investment Company, Inc.
- Reporting Manager
- AWM Investment Company, Inc.
- Security
- Oncocyte Corp Common Stock
- Symbol
- OCX
- Shares outstanding
- 17,417,453 shares
- Disclosed Ownership
- 1,306,309 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 14:41:23 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 09 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AWM Investment Company, Inc. disclosed 7.5% ownership in Oncocyte Corp Common Stock (OCX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 14:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 7.5% | 1,306,309 | 1,306,309 | Adam Stettner | Executive Vice President |